| Existing treatment strategies: does noncompliance make a difference? |
|
| Foundations of medical diagnosis: what actually are the parameters involved in Bayes' theorem? |
|
| Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events |
|
| The global pertussis initiative: Meeting report from the Regional Latin America Meeting, Costa Rica, 5-6 December, 2008. |
|
| The Hanover Consensus: Helpful for German Decision-Makers? |
|
| Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials |
|
| Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.K |
|
| HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis |
|
| Hospitalization for pertussis: profiles and case costs by age. |
|
| How cost-effective are drugs and devices used in cardiology? |
|
| How relevant is cost-effectiveness anyway? |
|
| Ignoring Study Design Heterogeneity in Meta-analyses |
|
| The impact of compliance with osteoporosis therapy on fracture rates in actual practice |
|
| Impact of Physical Functioning of Health Status on Hospitalizations, Physician Visits, and Costs in Diabetic Patients |
|
| Impact of thalassemia major on patients and their families |
|
| The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials |
|
| Improving Transparency in Decision Models: Current Issues and Potential Solutions |
|
| Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha |
|
| INTRODUCTION: PRACTICE GUIDELINES Helpful Aids or Paradigm Shift? |
|
| Invasive meningococcal disease epidemiology and control measures: a framework for evaluation |
|
| IQWiG methods - a response to two critiques |
|
| ISPOR-SMDM Task Force’s Recommendations for Good Modeling Practices—Reply to Letter to the Editor by Corro Ramos |
|
| Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S |
|
| Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation |
|
| Long term cost-of-illness in stroke: an international review |
|
| Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States. |
|
| Lung cancer screening: will the controversy extend to its cost-effectiveness? |
|
| Management patterns and costs of acute ischemic stroke: an international study. For the Stroke Economic Analysis Group. |
|
| Managing meningococcal disease in the United States: Hospital case characteristics and costs by age. |
|
| Medical planning and response for a nuclear detonation: a practical guide |
|
| Medical Research on a Complaint: Orientation and Priorities |
|
| Meta-analysis of longitudinal studies. |
|
| Metabolic effects of regular physical exercise in healthy population |
|
| Methods of economic evaluation for the German statutory healthcare system. |
|
| Les modèles quantitatifs pour l'évaluation du rapport bénéfice-risque des vaccins: état de l'art et axes d'amélioration |
![Sudoc [ABES], France](https://viaf.org/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
|
| Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States |
|
| Modeling the implications of changes in vascular calcification in patients on hemodialysis |
|
| Modelling the economic and health consequences of cardiac resynchronization therapy in the UK. |
|
| Modelling the health benefits and economic implications of implanting dual-chamber vs. single-chamber ventricular pacemakers in the UK. |
|
| Los modelos de simulación de eventos discretos en la evaluación económica de tecnologías y productos sanitarios |
|
| The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database |
|
| NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used? |
|
| No head-to-head trial? simulate the missing arms. |
|
| Optimizing oral anticoagulation in managed care |
|
| Optimizing the design of pragmatic trials: key issues remain |
|
| Oxybutynin Extended Release and Tolterodine Immediate Release |
|
| Pertussis Immunization of Adolescents in the United States |
|
| Pertussis in Adolescents and Adults: Should We Accept the Results? |
|
| Pharmacoeconomic analyses using discrete event simulation |
|
| Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder |
|
| [Pharmacoepidemiology in Mexico] |
|
| Pharmacokinetics in human populations |
|
| Pharmacological management of overactive bladder: a systematic and critical review of published economic evaluations |
|
| Potential strategies to reduce the burden of pertussis |
|
| Predicting Treatment Costs After Acute Ischemic Stroke on the Basis of Patient Characteristics at Presentation and Early Dysfunction |
|
| Prevention and management of hyperphosphatemia with sevelamer in Canada: health and economic consequences |
|
| Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting |
|
| Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. |
|
| Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions |
|
| The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry |
|
| Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care |
|
| Quantitative benefit-risk models applied on vaccines. |
|
| Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis |
|
| Re: "Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women" |
|
| Real-world effectiveness of antihypertensive drugs. |
|
| Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data |
|
| Regarding Probabilistic Analysis and Computationally Expensive Models: Necessary and Required? |
|
| Reply to vascular endothelial growth factor: a novel potential therapeutic target for hypertension |
|
| The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis. |
|
| Risk of discontinuation of risperidone after exposure to potentially interacting drugs: a nested case-control study in patients with schizophrenia |
|
| The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis |
|
| Scarce resources for nuclear detonation: project overview and challenges |
|
| Secondary prevention fallacy: pitfalls in comparing with primary |
|
| Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure |
|
| Strategies for the management of hypercholesterolaemia: a systematic review of the cost-effectiveness literature. |
|
| Stroke treatment economic model (STEM): predicting long-term costs from functional status. |
|
| Structural, energetic, and dynamic responses of the native state ensemble of staphylococcal nuclease to cavity-creating mutations. |
|
| Summary: health and economic burden of pertussis |
|
| The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada |
|
| To what degree does cognitive impairment in Alzheimer's disease predict dependence of patients on caregivers? |
|
| TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer |
|
| Treating acetaminophen overdose: thresholds, costs and uncertainties |
|
| Unaltered ethical standards for individual physicians in the face of drastically reduced resources resulting from an improvised nuclear device event. |
|
| Use of relative effectiveness information in reimbursement and pricing decisions in Europe |
|
| User-managed inventory: an approach to forward-deployment of urgently needed medical countermeasures for mass-casualty and terrorism incidents |
|
| The value of industry-sponsored studies of initial antihypertensive therapies. |
|
| The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. |
|
Preferred Forms
